Resveratrol: What It Is and How It Works

Resveratrol became famous as the "red wine molecule" that might explain the French paradox and slow aging. Two decades of research later, the picture is far more complicated. Our editors explain what resveratrol is, the mechanisms that made it famous, why it is hard for the body to use, and what that means for people who train.

What resveratrol is

Resveratrol is a polyphenol from the stilbene family. Plants produce it as a phytoalexin, a defensive compound made in response to fungal infection, ultraviolet light or injury. It is found in grape skins, peanuts, some berries and, in high concentration, in the roots of Japanese knotweed (Polygonum cuspidatum), which is the main commercial source today.

The molecule exists in two forms, trans- and cis-resveratrol. The trans form is the one most studied and the one supplement labels usually specify. It is sensitive to light, so storage and manufacturing affect how much active compound actually ends up in a capsule.

Public interest dates back to the early 1990s. Researchers seeking to explain why French populations had relatively low rates of coronary disease despite a rich diet pointed to red wine, an idea popularized as the "French paradox" and discussed by Renaud and de Lorgeril in The Lancet in 1992. Resveratrol was one of the candidate compounds.

The amounts in food are small, however. Red wine typically contains only a few milligrams per liter at most, while supplements commonly provide 100 to 500 mg or more per serving. Any effect seen with supplements therefore cannot be equated with drinking wine, and our editors do not regard wine as a meaningful source.

How it is thought to work

The modern resveratrol boom began in 2003, when Howitz and colleagues reported in Nature that it activated sirtuins, a family of enzymes linked to the life-extending effects of calorie restriction in yeast. In 2006, Baur and co-workers showed that mice on a high-calorie diet given resveratrol lived longer and had better metabolic health than untreated mice on the same diet.

Those findings triggered enormous commercial interest. Yet subsequent work questioned the direct mechanism: a 2010 paper by Pacholec and colleagues found that resveratrol's apparent activation of SIRT1 depended on the fluorescent substrate used in the original assays. The current view is that resveratrol influences many pathways, some indirectly.

• AMPK activation: resveratrol can activate AMP-activated protein kinase, an energy sensor that also responds to exercise.
• Sirtuin signaling: effects on SIRT1 appear real in cells but may be indirect and context-dependent.
• Antioxidant and anti-inflammatory actions: shown in laboratory settings, often at concentrations higher than those reached in human blood.
• Vascular effects: possible improvements in endothelial function and nitric oxide availability.

A recurring problem is that many striking effects appear in cell cultures or rodents at doses that would be very large for humans. Translating these mechanisms into reliable human benefits has proven difficult, which is a theme across the entire resveratrol literature.

Human trials have produced mixed results. A small 30-day study by Timmers and colleagues in 2011 reported calorie-restriction-like metabolic changes in obese men, while other trials in healthy or non-obese people found little effect on insulin sensitivity, blood pressure or body composition.

Absorption and bioavailability

Resveratrol is absorbed reasonably well from the gut, but it is metabolized so quickly that little free resveratrol reaches the circulation. Walle and colleagues showed in 2004 that roughly 70% of an oral dose was absorbed, yet only trace amounts of unchanged resveratrol appeared in plasma because the liver and intestine rapidly convert it to glucuronide and sulfate conjugates.

This is often summarized as "high absorption, low bioavailability." Researchers debate whether the conjugated metabolites have their own activity or can be converted back to resveratrol in tissues, but this remains unresolved.

Manufacturers have responded with micronized powders, liposomal products and combinations with piperine, which may slow metabolism. Evidence that these forms deliver better outcomes, rather than just higher blood readings, is limited.

Taking resveratrol with a meal, especially one containing fat, tends to slow absorption and lower peak levels, though overall exposure may be similar. For practical purposes, consistency matters more than precise timing.

Resveratrol and exercise

For athletes, the most relevant studies are not encouraging. Because resveratrol activates AMPK, it was promoted as an "exercise mimetic" that might enhance endurance. Some rodent studies supported this, but human data tell a different story.

A 2013 trial by Gliemann and colleagues in The Journal of Physiology gave aged men 250 mg of resveratrol per day during eight weeks of high-intensity training. Rather than adding benefit, resveratrol blunted several positive training effects, including improvements in blood pressure, cholesterol and maximal oxygen uptake.

The likely explanation parallels findings with high-dose antioxidant vitamins: some oxidative and inflammatory signaling after exercise is part of the stimulus that drives adaptation. Dampening it can interfere with the very process training is meant to trigger.

Not every study has found harm; some trials in older adults reported neutral effects. Still, our editors consider the possibility of blunted adaptation a reason to think carefully before combining large doses with a serious training program.

Using it sensibly

In the United States, resveratrol is sold as a dietary supplement and is not approved by the FDA to treat any condition. Doses used in human research typically range from about 150 mg to 1,000 mg per day, with some studies going higher. Short-term use within that range is generally well tolerated.

The most common side effects at higher doses are digestive: nausea, loose stools and abdominal discomfort. Resveratrol may have mild antiplatelet effects, so people taking anticoagulants or antiplatelet drugs should consult a doctor. It may also interact with drugs metabolized by certain liver enzymes.

Because resveratrol has weak estrogen-like activity in some laboratory models, people with hormone-sensitive conditions should be cautious and seek medical advice. Pregnancy and breastfeeding are not well studied.

If an athlete chooses to use it, a reasonable approach is to keep doses moderate, avoid taking it immediately around key training sessions, and evaluate whether it adds anything measurable. Products with independent quality testing are preferable because label accuracy varies.

Conclusions of the editorial team

Resveratrol is a genuinely interesting plant compound whose reputation ran ahead of the evidence. Its laboratory biology is rich, but its human effects are modest, inconsistent and limited by rapid metabolism.

For people who train, there is no solid case that it improves performance, and at least one well-designed trial suggests it may interfere with cardiovascular adaptations to exercise.

It may still have a place in research on metabolic health, but it is not a shortcut to longevity or fitness. Diet quality, training and sleep remain the foundations.

Readers may also find useful our articles on antioxidants and training adaptation, on the evidence behind NAD+ precursors, and on quercetin as a sports supplement.

References

1. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992;339(8808):1523–1526.
2. Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425(6954):191–196.
3. Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004;32(12):1377–1382.
4. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444(7117):337–342.
5. Pacholec M, Bleasdale JE, Chrunyk B, et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem. 2010;285(11):8340–8351.
6. Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011;14(5):612–622.
7. Gliemann L, Schmidt JF, Olesen J, et al. Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men. J Physiol. 2013;591(20):5047–5059.